Treatment
Treatment for breast cancer depends on its specific type, its stage and the patient's overall health. The specific type of breast cancer is determined by the tumor’s histologic type (i.e. ductal carcinoma, lobular carcinoma and other rare types - see Types of Breast Cancer), hormone receptor status and HER2/neu status. Treatment usually involves surgery to remove the primary tumor, and may also include radiation therapy, chemotherapy, hormone therapy or targeted therapy. The doctor may give treatments before surgery (neoadjuvant therapy), to shrink the tumor. Or, the doctor may give additional treatments after surgery (adjuvant therapy), to destroy any remaining cancer cells in the body.
Surgery
Most women with breast cancer have breast-conserving surgery or a mastectomy to remove the tumor, along with lymph node surgery to check the lymph nodes for cancer that may have spread. Some women may also decide to have reconstructive surgery after undergoing breast cancer surgery to remove the tumor.
Radiation therapy
Radiation therapy uses waves of high energy beams to target and kill cancer cells. Doctors often give radiation after surgery (adjuvantly) to reduce the chance that the cancer will return. There are two primary types of radiation therapy: external and internal.
Please refer to Radiation Therapy for Breast Cancer for more information about preparing for treatment, what to expect, possible side effects and tips to manage side effects.
Chemotherapy
Chemotherapy is the use of drugs to target rapidly growing cells to destroy cancer cells. Doctors give chemotherapy to shrink the tumor before surgery (neoadjuvant therapy) and destroy any traces of cancer left after surgery (adjuvant therapy). In more advanced stages in which the cancer has spread, chemotherapy may be the best treatment option to relieve symptoms and improve survival. Chemotherapy can be given intravenously, as a shot, or as a pill or liquid. Doctors usually use a combination of chemotherapy drugs and give the treatment in cycles. This means that each round of treatment will be followed by a rest period of one to three weeks. Your doctor may discuss Oncotype DX a genomic test for breast cancer that evaluates a patient's risk of reoccurence and likely response to chemotherapy.

Endocrine Therapy/Hormone Therapy
Some women have breast cancer that is hormone-receptor positive. In these women, estrogen and progesterone hormones may cause the tumor to grow more aggressively. Endocrine therapy blocks the effects of these hormones or lowers their levels, preventing the hormones from fueling cancer growth. Doctors often give endocrine therapy to reduce the risk of the cancer returning after surgery.

Targeted Therapy
HER2/neu is a protein that is present in breast cancer cells that helps control how a cell grows, divides, and repairs itself. In about 1 in 5 cases of breast cancer, the HER2 gene doesn’t work correctly and makes too many copies of itself. This HER2 over-expression makes the cancer grow more aggressively and uncontrollably. Targeted therapy specifically targets these HER2 proteins, stopping or slowing the growth of breast cancer.
PARP inhibitors work by preventing cancer cells from repairing themselves, allowing them to die. PARP inhibitors preferentially kill cancer cells at the BRCA mutation over normal cells. Your doctor may recommend a PARP inhibitor for maintenance therapy after initial therapy or for treating recurrence.

Immunotherapy
Immunotherapy is a new cancer treatment that stimulates the body's immune system to attack cancer cells. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. This type of cancer treatment is also called biotherapy or biologic therapy. The area has evolved with complexity. Furthermore, these treatments are combined in many different ways.
.

Bone-directed Therapy
Doctors use bisphosphonates (Zometa, Pamidronate) to treat breast cancer that has spread to the bones. Bisphosphonates strengthen bones that have been weakened by cancer cells and reduce the risk of fractures and breaks. Bisphosphonates can reduce cancer-related bone pain and hypercalcemia (elevated calcium levels in the blood), and may help prevent thinning of the bone (osteoporosis).

Clinical Trials
Clinical trials allow patients to try a new treatment before it is available to the general public. In some cases, this may be a new drug that has not been used in humans before, or it may be a drug or drug combination that is not currently used for that specific type of cancer. Early phase clinical trials are often used to test side effects of a drug or drug combination, while later phase clinical trials are used to see how effective a new treatment might be for a certain type of cancer. Clinical trials allow doctors and researchers to improve the treatment of cancers with possibly more effective therapies. A clinical trial may be a new, groundbreaking drug or it may have no effect. It is important to talk with your doctor about the pros and cons of clinical trials for your particular situation.